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INTRODUCTION 
Ankylosing spondylitis is a chronic inflammatory disorder primarily 
affecting the sacroiliac joints and vertebral column, often manifesting  in young 
males than in females in the ratio of 3:1 in the second or third decade. 
Even though ankylosing spondylitis is principally a disease of axial and 
peripheral joints, extraarticular manifestations of the disease are also common, 
affecting Cardiac, ophthalmic, pulmonary, renal and neurological systems.  
Ankylosing spondylitis has a worldwide prevalence of 0.1 to 1.4%.  The 
prevalence of rheumatoid arthritis among Indian population is found to be  
0.85%.  According  to Yang et al, the prevalence of cardiac manifestations in 
ankylosing spondylitis patients were found to be 10% to 30% 
Bulkley and Roberts were one of the first to put forward 
pathophysiologic description of valvular heart diseases in ankylosing 
spondylitis, when they studied autopsy findings in eight patients with 
ankylosing spondylitis. They demonstrated aortic root dilatation, with a cellular 
inflammatory process with fibroplast overactivity along with tissue thickening 
involving the aortic cusps, aortic annulus, conduction system leading to aortic 
regurgitation and conduction abnormalities in patients with ankylosing 
spondylitis. 
Thereafter a lot of research works were carried out regarding the cardiac 
manifestations in patients with ankylosing spondylitis and found that aortic 
regurgitation, aortic root dilatation and conduction disturbances were the most 
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common abnormalities. The other associations were pericarditis, myocarditis, 
left ventricular diastolic dysfunction, mitral regurgitation. 
The cardiac manifestations in ankylosing spondylitis can be 
symptomatic or asymptomatic. Hence the patients with ankylosing spondylitis 
should be screened for cardiac abnormalities by electrocardiography and 
echocardiography. 
O‟Neill, T. W.et al,34(1992)  found out that 29% of patients with 
ankylosing spondylitis were associated with cardiac abnormalities.The 
abnormalities were found in patients with ten or  more than ten years duration. 
Cardiac abnormalities associated were aortic incompetence, pericardial 
effusion and conduction disturbances.  
Park et al, depending on the disease duration, found out the early 
valvular involvement in young males with ankylosing Spondylitis using 
transoesophageal echocardiography. They measured the aortic valve thickness, 
mitral valve thickness, aortic root diameter. 
Many studies were carried out in relation to cardiovascular 
manifestations in ankylosing spondylitis and  had found that the association of 
cardiac manifestations increased with increased duration of ankylosing 
spondylitis , increase in the age of the patient. 
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AIMS AND OBJECTIVES: 
AIM: 
        To find the prevalence of cardiovascular manifestations in patients 
suffering from Ankylosing Spondylitis. 
OBJECTIVES: 
 To observe the cardiovascular manifestations in patients with 
Ankylosing Spondylitis  by  chest X Ray, electrocardiography  and 
echocardiogram compared with the controls. 
 To find out the relation between cardiac lesions with the age, sex of the 
patient, clinical parameters, Grading by X Ray and duration of  
Ankylosing Spondylitis.  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
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HISTORICAL ASPECTS: 
Anatomical descriptions of two skeletons typical of ankylosing 
spondylitis was given by Realdo de Colombo in 1559. Later several 
descriptions of ankylosing spondylitis came in the nineteenth century.  Sir 
Benjamin Brodie  in 1850, described ankylosing spondylitis in a man whose 
disease started at 27 years of his age and became  completely rigid after 6 years 
with a „hoop-like‟ deformity of the spine and associated with inflammation of 
the eyes. This was the first reported case of uveitis in a patient with ankylosing 
spondylitis.  
Charles Fagge , a clinician at Guy‟s Hospital  in 1877 described cardiac, 
pulmonary manifestations in a man of 34 years. Bechterew, a neurologist who 
in 19
th
 century described  neurological manifestations in three patients, a 
mother and daughter and a man who had  incurred  trauma to his back in the 
past. With the clinical data he assumed a chronic process of the vertebrae  
leading to ankylosis which probably leads to a diffuse chronic inflammation of 
the epidural connective tissue with pressure  on the nerve roots, that 
sufficiently explains the rigidity or stiffness of the vertebral column, as well as 
the sensory symptoms of the spinal nerve roots with weakness  of the muscles 
of the neck, back and upper extremities. Bechterew favoured a genetic 
predisposition for ankylosing spondylitis since he observed the disease in both 
mother and the daughter.  
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Berlin Adolph Strűmpell  in 1897, described two patients with complete 
ankylosis of the spine and of both hip joints. He emphasised  lumbar lordosis in 
a rigid spine as a prominent feature and published  photographs of such 
patients. Strűmpell labelled the disease in more descriptive terms as „chronic  
inflammation of the large joints and vertebral column‟. 
Pierre Marie in 1926 gave the detailed and characteristic clinical 
description of ankylosing spondylitis and coined the word „spondylose 
rhizomélique‟. He gave detailed descriptions of six male patients. He worked 
as an assistant to Jean Marie Charcot at the Salpêtrière Hospital before 
becoming Professor of Neurology. Léri, Marie‟s assistant, described the full 
pathological characteristics of ankylosing spondylitis after he had carried out 
autopsies on two of Pierre Marie‟s patients. His conclusions anticipated 
modern developments.  
Ankylosing spondylitis, hence named after the major contributors of the 
description of the disease as Bechterews disease or Marie – Strumpell disease                                 
Association of ankylosing spondylitis with aortic incompetence was described 
by Charles W Hufnagel in 1956, when 100 patients with prosthetic aortic valve 
were reviewed. Among them he found five patients had Ankylosing 
spondylitis.  
DEFINITION  OF ANKYLOSING SPONDYLITIS: 
Ankylosing spondylitis (AS) is a chronic inflammatory disorder 
predominantly affecting the sacroiliac joints and vertebral column which often 
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manifests in young males than in females in the second or third decade. 
Extraarticular manifestations of the Ankylosing spondylitis includes arthritis of 
the peripheral joints, enthesitis, anterior uveitis, prostatitis, cardiac and 
pulmonary manifestations
1,2
 
ETIOLOGY:  
Etiology of Ankylosing spondylitis is multifactorial, based on 
endogenous and exogenous causes. Endogenous factors involve the genetic 
component with increased prevalence of the disease in the population with 
HLA-B27 gene located in the chromosome 6 with increased familial 
recurrence
3  
Other genes that encode for the production of pro-inflammatory 
cytokines, like interleukin1 ( chromosome 2q14), Interleukin 1 alfa and beta 
polymorphisms, as well as the polymorphisms of its functional antagonist the 
interleukin 1 receptor antagonist gene.  CARD 15, related to Crohn‟s disease4 
and the gene encoding for the human Transforming Growth Factor B1 
(TGFB1) , a regulator of osteoblast proliferation also plays a role.
5
  Exogenous 
factors involve certain bacterial infections like salmonella and Chlamydia. 
PATHOLOGY OF ANKYLOSING SPONDYLITIS 
The disease involves both axial and peripheral skeleton, though the axial 
skeleton gets involved at the earliest. Inflammation in the fibrocartilagenous 
enthesis, the region where a tendon, ligament, or a joint capsule attaches to 
bone, is a characteristic lesion in AS and other spondyloarthritides, both at 
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axial and peripheral sites. This enthesitis is associated with prominent edema of 
the adjacent bone marrow and is often characterized by erosive lesions that 
eventually undergo ossification.  
 Sacroiliitis is often the earliest manifestation of AS. Synovitis,the 
earliest change will be followed by pannus and subchondral granulation tissue 
formation. This is followed by fibrocartilage regeneration of eroded joint 
margins and then by ossification. 
Spinal specimens studied have shown inflammatory granulation tissue  
at the junction of annulus fibrosus with the vertebral bone. The outer annular 
fibres are eroded and eventually replaced by bone, forming the beginning of a 
syndesmophyte, which then grows by continued enchondral ossification 
eventually bridging the adjacent vertebral bodies thus giving rise to a “Bamboo 
Spine”. Erosion of joint cartilage by pannus formation is often followed by 
bony ankylosis. Bone mineral density is diminished in the spine and proximal 
femur early in the course of the disease.  
The features of peripheral arthritis in AS and other forms of  SpA are 
similar, and distinct from those of rheumatoid arthritis.  Synovitis is associated 
with marked vascularity, evident as tortuous macrovascularity seen during 
arthroscopy. Lining layer hyperplasia, lymphoid infiltration and pannus 
formation are also found. Proliferation of subchondral granulation tissue 
leading to central cartilaginous erosions are common. 
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Subclinical  intestinal  inflammation in the colon and distal ileum has 
been found in a majority of patients with AS and other forms of SpA.  Acute 
lesions resemble bacterial enteritis with largely intact  architecture and 
neutrophilic infiltration in the lamina propria. The chronic lesions are 
associated with distortion of crypts and villi, aphthoid ulceration and 
mononuclear cell infiltration in the lamina propria. 
PATHOGENESIS OF ANKYLOSING SPONDYLOSIS 
The pathogenesis is immune-imediated with evidences suggesting more 
of an autoinflammatory process rather than antigen-specific autoimmunity. 
TNF-α, a cytokine plays a central role in the immunopathogenesis of AS as 
evidenced by the therapeutic response to anti-TNF-α drugs. More recent 
evidence stongly implicates the IL-23 / IL-17 cytokine pathway in AS 
pathogenesis. The genes implicated are  IL-23,  IL12B, and CARD9. Serum 
levels of IL-23 and IL-17 are elevated in AS patients. IL-17 is largely produced 
by mast cells and to a lesser extent by neutrophils in the setting of peripheral  
arthritis  in AS where as neutrophils are the major IL-17 producing cells in 
apophyseal joints.  High levels of circulating  γδ  T cells expressing IL-23 
receptors and producing IL-17 have been found in AS patients.  
CD4+ and CD8+  T cell and macrophage infiltration with high levels of  
TNF-α are found in the inflammed sacroiliac joints, early  in the disease. More 
advanced lesions show abundant levels of TGF-β. Peripheral synovitis show 
abundant neutrophils, and macrophages expressing CD68 and CD163, CD4+ 
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and CD8+ T cells and B cells. Intercellular Adhesion Molecule 1 (ICAM-1), 
Vascular Cell Adhesion Molecule ( VCAM-1) , Matrix Metallo Proteinase ( 
MMP-3) , and Myeloid Related Proteins (MRP 8 and 14) are also implicated in 
the pathogenesis. 
Overlapping  features with reactive arthritis and IBD and involvement of  
IL-23/IL-27 pathway suggest that  enteric bacteria  may play a role, and 
microdamage  from mechanical stress at enthesial sites has also been 
implicated.  
Though the  association of HLA-B27  with AS and its direct role in AS 
pathogenesis has been firmly established, its exact role at the molecular level 
remains unresolved. Several theories have been postulated as possible 
mechanisms, with or without the involvement of antigen presentation. Also,  a  
role for natural killer cells has also been suggested  possibly through 
interactions between B27 heavy chain homodimers and killer cell 
immunoglobulin like receptors inducing pro-inflammatory leukocytes in the 
disease. 
Recent evidences point out a strong association between ERAP 1 
(Endoplasmic Reticulum Amino Peptidase 1) and HLA-B27 positive 
ankylosing spondylitis. ERAP 1  in these patients have lower aminopeptidase 
activity than the normal individuals and this combined with HLA-B27  heavy 
chain has higher tendency to misfold and  pay way for a strong pro-
inflammatory milieu. 
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New bone formation in AS is largely due to enchondral bone formation 
and whether this is secondary to inflammation or not is a matter of debate. 
Evidences point out to lack of regulation in Wnt signal transduction pathways 
which controls the osteophyte formation with the help of inhibitors like DKK 
1(Dickkopf Related Protein 1) and Sclerostin. Anti-TNF-α therapy suppresses 
the ongoing inflammation whereas it fails to suppress new bone formation 
suggesting an independent mechanism for new bone formation. However, 
recent evidences based on MRI studies reveals that prolonged inflammation at 
enthesial sites leads to fatty tissue metaplasia and this subsequently becomes 
the predominant site for syndesmophyte formation. However, recent evidences 
suggest that continued Anti-TNF-α therapy may decrease the rate of this 
syndesmophyte formation.  
CLINICAL FEATURES:   
Average age of onset of the disease is about 28 years but can also occur 
in children, called as juvenile onset AS, dominated by peripheral arthritis.Onset 
after the age of 45 years is very uncommon. The complaints in AS are often 
gradual with mean delay of 8 years from the onset of first symptoms to the 
onset of diagnosis. The disease occurs more common in males with a male to 
female ratio of approximately 3:1. The age of onset is slightly higher in 
females
6
.  In men the disease manifestations are most commonly located in the 
spine and pelvis, whereas in women it commonly involves the peripheral joints 
and pelvis
7
. The disease tends to be more severe in men with a higher incidence 
of uveitis. 
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Spinal manifestations:  
The spinal involvement results in chronic inflammatory back ache with 
morning stiffness caused by inflammation of the sacroiliac (SI) joints and 
vertebral column. Morning stiffness improves with exercise and lasts atleast for 
one hour. Sacroiliitis,the most important characteristic of AS can be detected 
by a conventional radiograph of the pelvis showing blurring of the distal part of 
the SI-joints, progressing to joint space narrowing and finally sclerosis of the 
joints. At initial stage Magnetic Resonance  Imaging(MRI) is more sensitive
8
. 
Involvement of the cervical and costovertebral joints causes pain in the cervical 
and thoracic spine especially with chest expansion. 
Spinal inflammation coincides with the formation of syndesmophytes 
and squarring of the vertebrae, causing classical bamboo spine  which leads to 
spinal ankylosis with limitation of chest expansion and neck movements and 
flattening of the lumbar spine and thoracic kyphosis resulting in a stooped 
forward posture. 
 Atlanto-axial subluxation might occur due to erosions of the transverse 
ligaments that leads to neurological complications. Osteoporosis occurs in 
patients with syndesmophytes peripheral joint involvement which leads to 
fractures even after a minor trauma. Another spinal complication is non-
infectious spondylodiscitis which occurs in approximately 8% of the AS 
patients, predominantly at the thoracic and lumbar levels. 
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Figure 1: Bilateral sacroiliitis 
                               
 
Figure 2: Spinal inflammation with syndesmophytes 
The disease activity is measured by BASDAI (Bath Ankylosing 
Spondylitis Disease Activity Index). It consists of a scale from 1 to 10, with 
respect to the increase in the severity of the problems. It consists of 6 questions 
with 5 major problems. 
 Incresae in tiredness 
  Pain over the spine 
 Swelling or pain over the joint  
13 
 
  Extra articular tenderness 
  Duration of morning stiffness and 
  Severity of morning stiffness. 
To give equal weighting to each symptom, the mean of two scores 
relating to morning stiffness is taken. The resulting 0 to 50 score is divided by 
5 to give a final 0 – 10 BASDAI score. Scores of 4 or greater suggest 
suboptimal control of disease and those are usually good candidates for either a 
change in their medical therapy or for enrollment in clinical trials evaluating 
new drug therapies directed at Ankylosing Spondylitis. BASDAI is a quick, 
simple and reliable index for treatment outcome.  
EXTRASPINAL MANIFESTATIONS: 
Arthritis:  
Peripheral arthritis usually occurs in one third of the patients, especially 
in the knees,  shoulders and hips
9
. Hip involvement is common in the juvenile-
onset and is usually bilateral which occurs mainly in the first ten years of the 
disease.This leads to flexion contracture and destruction of the affected hip 
joint that ultimately requires joint replacement.Shoulder joints are also usually 
involved. Knees, wrists, elbows and feet are usually involved in an 
asymmetrical pattern. Radiographic features show bony ankylosis.  
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Figure 3: Arthritis of knee joint in AS 
Enthesitis:  
 Enthesitis, an extra-articular bony tenderness caused by local 
inflammation causes pain. Many sites can be involved  like costosternal 
junctions,  spinous processes, iliac crests, greater trochanters, ischial 
tuberosities, tibial tubercles or tendons insertions like the Achilles tendons
10
.  
 
Figure 4: Heel enthesitis in AS 
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Ocular: 
Acute anterior uveitis  occurs in 25-30% of the patients with ankylosing 
spondylitis and that can be the first presenting symptom of the disease.It is 
characterised by recurrent, unilateral sudden ocular pain with redness and 
photophobia. The occurrence of acute anterior uveitis is increased in the HLA-
B27 positive population. 
These attacks causes inflammatory debris accumulating in the anterior 
chamber which may cause papillary and lens dysfunction which leads to 
blurring of vision. In few cases glaucoma and even blindness may occur if 
adequate treatment is delayed but most of the time the uveitis resolves 
spontaneously within 3 months. 
Uveitis can be treated by local corticosteroids or TNF-blocking agents 
like infliximab which seems to be successful in refractory uveitis 
11
 . 
                                       
Figure 5: Anterior Uveitis in AS 
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Gastro – Intestinal: 
Inflammatory bowel disease is described in a high percentage of patients 
with spondyloarthropathy (60%) and can be detected by endoscopy of the 
colon and terminal ileum
12
.  These lesions can be divided into acute lesions 
resembling acute bacterial infections and chronic lesions with features of 
inflammatory bowel disease. 
The chronic lesions are more often seen in association with  AS  and  
although these enteric mucosal lesions most of the time are clinically silent, 
patients with chronic lesions experience significantly more episodes of 
diarrhea.  During follow up studies it appeared that up to 25% of these AS 
patients with peripheral arthritis and chronic gut inflammation  eventually 
develop Crohn‟s disease13 . 
Pulmonary: 
Pulmonary complications can be caused by rigidity of the chest wall and 
apical pulmonary fibrosis. In a retrospective study, an incidence of apical 
pulmonary fibrosis in AS was reported in 7%, based on plain 
radiography
14
.This complication occurs, on average, two decades after the 
onset of AS, but recent studies with high resolution computed tomography 
(HRCT) detected interstitial lung disease in 50 –70 % of the patients with early 
AS, defined as a duration of < 10 years
15
 patients. Cavities in the fibrotic parts 
can be infected by bacteria and fungi like Aspergillus. 
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 These cavitations mimic tuberculosis in one thirds of the patients. 
Chronic aspergillus colonization is reported in 50-65% of patients with AS, 
whereas 10-30% develop an aspergillosis infection. Treatment is based on the 
administration of antifungal drugs  with surgical resection of the cavity and 
removal of the fungal ball. The inflammation of costovertebral and 
costotransverse joints do not reduce the pulmonary function. The total lung and 
vital capacities are seldom reduced in AS patients, despite the diminished chest 
expansion, because the diaphragmatic function is not impaired . 
 
Figure 6: Chest X Ray with bilateral upper and mid zone fibrosis 
RENAL: 
Renal abnormalities in Ankylosing Spondylitis varies with an incidence 
16
 between 10-18%. These include 
  a.Secondary renal amyloidosis , most common in AS (62%). 
  b.IgA-nephropathy (30%). 
  c. mesangioproliferative glomerulonephritis (5%)  
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Other rare associations could be membranous nephropathy and Focal 
segmental glomerulosclerosis. 
Renal amyloidosis is to be considered in case of proteinuria and renal 
failure in AS. In 7% amyloid can be found in abdominal fat or rectal biopsies, 
but most  do not develop clinically significant disease.  Proteinuria or impaired 
renal function can indicate IgA-nephropathy, which is interesting because of 
the increased serum IgA levels in AS patients. Cases of IgA multiple myeloma 
have also been reported.   
Neurological: 
Vertebral fractures, especially of the cervical spine,  and cervical spine 
dislocations can cause neurological deficits after minor trauma.  A slowly 
progressive cauda equina syndrome might occur late in the disease course as a 
rare complication, first described by Browie and Hauge in 1961.
17
  
The symptoms are a sensory loss in the lumbar and sacral dermatomes 
with weakness in the legs and bowel and bladder incontinence
18
. MRI can 
demonstrate arachnoiditis, with characteristic enlarged dural sacs and 
arachnoid diverticula . One study with CT-scan also showed dural calcification. 
Treatment with NSAIDs or corticosteroids alone is inappropriate to improve 
the neurological deficit and often surgical treatment of the dural ectasia, by 
lumboperitoneal shunting or laminectomy is necessary. 
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Hormonal: 
The elevated susceptibility for AS in men compared with women did 
suggest an etiological role for sex steroids in AS. In male patients, elevated 
serum testosterone and in premenopausal females lower 17β–estradiol levels 
were reported. It was even suggested that anti-androgenic treatment would be 
beneficial for AS patients
19
.  
However, more recent studies revealed that serum testosterone levels are 
not elevated in male AS patients, but previous found elevations might be 
explained due to the use of phenylbutazone . Therefore,  no basis is provided 
for anti-androgenic treatment. Also, the 17β-estradiol levels in later studies did 
not differ between AS patients and controls. The influence of hormones like 
prolactin and growth hormone, which might have a pro-inflammatory effect, 
were recently studied in men with AS and  Rheumatoid Arthritis(RA).  
Cardiac Manifestations: 
     Cardiac involvement in Ankylosing spondylitis can occur in the form of  
 a. aortic valve incompetence, aortitis of the ascending aorta 
 b. conduction abnormalities.  
 c.Mitral Regurgitation 
 d. Myocardial involvement with Left ventricular dysfunction 
 e. Cardiomyopathy and Pericarditis can also occur. 
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Conduction Disturbances: 
 Inflammation and fibrosis of the membranous portion of the 
interventricular septum  and that affecting the atrioventricular node leads to 
conduction disturbances
20
. The occurrence of conduction disturbances in 
patients with AS varies from 1-33%. It can result in any form of heart block. 
First degree heart block is very common among them. Sometimes patients may 
require pacemaker implantation in case of a complete heart block. Conduction 
disturbances increases with increased duration of the disease. 
Aortic Regurgitation: 
1 – 10% of patients with ankylosing spondylitis will have  Aortic 
insufficiency. Age and duration of the disease increases the incidence of aortic 
insufficiency
21,22
 .  Inflammatory process affecting the aortic wall leading to 
fibrotic thickening and shortened aortic valve cusps and a dilatated aortic root 
resulting in aortic regurgitation
23,24
 .  
The aortic insufficiency results in volume overload to the left ventricle 
with eccentric hypertrophy and dilatation of the chamber. This results in 
increased end diastolic pressure in the left ventricle and ultimately resulting in 
heart failure in several years. The patient presents with chest pain and dyspnoea 
which often leads to Aortic valve replacement as the effective therapy
25
.  
The occurrence of mitral regurgitation, myocardial involvement with 
left ventricular dysfunction, cardiomyopathy and pericarditis in ankylosing 
spondylitis is rare.  
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Physical examination: 
 Blood pressure should be measured to exclude hypertension in case of 
renal involvement or aortic insufficiency in ankylosing spondylitis and pulse 
rate to detect bradycardia and irregular rhythm in case of atrioventricular 
conduction disturbances.  
Psoriatic lesions should be looked for in the skin, nails. The skin over 
the ears, scalp, natal region, extension surfaces of the elbows and knees and 
pitting lesions of the nails since psoriatic arthritis may mimic ankylosing 
spondylitis.  
The eyes should be examined for redness in  case of pain and blurring of 
vision which may be caused by conjunctivitis or an attack of acute anterior 
uveitis. An irregular pupil may result from an attack of uveitis in the past with 
synechiae to the cornea or lens, which might cause glaucoma in the long term . 
Examination of the heart to detect a murmur caused by aortic insufficiency and 
in such patients collapsing pulse and peripheral signs of aortic regurgitation 
should be looked for and bilateral basal crepts and jugular venous pulsations 
and pressure should be measured in case of heart failure. Bradycardia should be 
looked in case of cardiac conduction abnormalities.  
The chest might show signs of a limited chest expansion and crepts in 
case of apical fibrosis, although these lung deformities often can only be 
detected by radiographic procedures. The abdomen should also be examined, 
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but signs of inflammatory bowel disease most often are detected only with 
ileocolonoscopy.  
 Physical examination of the spine involves the cervical, thoracic and 
lumbar region.  Cervical involvement occurs late in the disease which can 
result in a limited flexion, extension, rotation or lateral flexion movements.  
The stooping of the neck can be measured by the occiput-to-wall distance. The 
patient stands with the back and heels against the wall and the distance between 
the back of the head and the wall is measured. Eventually the neck become 
fixed in a flexed position.   
The thoracic spine can be tested by measuring the chest expansion, the 
difference between deep inspiration and expiration which normally exceeds 5 
cm, that is  measured at the level of  fourth intercostal space in men just below 
the breasts in women. It is age- and sex-dependent, with lower expansion in 
females compared with males and decreases with age.           
A chest expansion of less than 5 cm is suspicious and < 2.5 cm is 
abnormal and raises the possibility of AS unless there is other reason like 
emphysema. In progressed AS, the anterior chest wall becomes flattened, 
shoulders become stooped, the abdomen becomes protuberant and the 
breathing diaphragmatic. The normal thoracic kyphosis of the dorsal spine 
becomes accentuated.   
The costovertebral, costotransverse and  manubriosternal joints should 
be palpated to detect inflammation which causes pain on palpation.  
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The lumbar spine can be tested by modified Schobers test which tests 
the ability of the patient to bend forward to touch the floor by the fingertips 
with the knees fully extended. This detects limitation of the forward flexion of 
the lumbar spine.  
This is performed by making a mark between the posterior superior iliac 
spines at the 5th lumbar spinous process. A second mark is placed 10 cm above 
the first one and the patient is asked to bend forward with extended knees. The 
distance between the two marks increases from 10 to at least 15 cm in normal 
people, but only to 13 or less in case of AS.  
Lumbar lateral flexion can be tested by the patient standing erect with 
the arms along side the body and by moving laterally with the fingers over the 
lateral side of the leg. The distance between the  measurement can be repeated 
on the other side.  
Signs of synovitis include pain, swelling, tenderness and limited motion 
of the joint and it should be looked for in all peripheral joints. The hips and 
shoulder are most often involved in one-third of the patients, and any 
limitations in function should be recorded early in the disease in order to detect 
progression later. Other joints often involved are the knees, wrists, elbows. The 
presentation is usually asymmetric and often monoarticular or oligoarticular.  
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INVESTIGATIONS:   
Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP), 
an acute phase reactant seem to be elevated in 50-70% of the patients with an 
active disease. 
26 
These parameters show a  higher correlation with peripheral 
involvement of ankylosing spondylitis than with spinal disease activity.  
In contrast with rheumatoid arthritis, these acute phase reactants do not 
have a high correlation with the disease activity of AS and elevation is more 
often observed in case of extraspinal manifestations than in case of more axial 
involvement. Therefore,  their value as an outcome parameter for disease 
activity in therapeutic trials in AS is limited.   
The platelet count may also be slightly elevated and a mild 
normochromic normocytic anaemia, due to a chronic disease is common in 
15% of the patients. Positive tests for the rheumatoid factor and ANA do not 
occur more often than in healthy controls. The HLA-B27 antigen is present in 
the majority of the AS patients, but this test is inappropriate  to confirm the 
diagnosis, which is primarily based on history, physical examination and 
radiographic evidence of sacoiliitis. In adolescent patients where the 
radiographic confirmation of sacroiliitis can be difficult, HLA-B27 testing 
could be helpful to establish the diagnosis.  
Raised alkaline phosphatase, primarily derived from bone and serum 
IgA levels are common in AS. The urine might show protein or erythrocytes in 
case of renal involvement.   
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Radiology  
The radiograph of the pelvis is necessary to assess the sacroiliac joints 
(SI), which might show signs of sacroiliitis, an obligatory sign for the diagnosis 
of AS. The severity of this  sacroiliitis can be graded from 0 (no abnormalities) 
to grade 4 (complete ankylosis of the SI-joints). At early stages of the disease, 
signs of sacroliitis can be detected with CT and MRI before the abnormalities 
are present at the plain radiograph of the pelvis.  
Also, the vertebral column often shows characteristic changes, like bony 
sclerosis with squaring of the vertebral bodies and ossification of the annulus 
fibrosis with syndesmophytes. This might lead to fusion of the vertebral 
column with a classical Bamboo-spine aspect on the radiograph of the lumbar 
region. Involvement of the hip and shoulder joints with joint space narrowing 
can be detected by conventional X Rays. 
 
Figure 7: Bamboo spine appearance of vertebral column in AS 
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Grading of Sacroiliitis by plain radiographs according to the modified New 
York Criteria: 
 Grade 0:  Normal 
Grade 1:  Suspected changes 
Grade 2:  Small areas with erosions or sclerosis without joint width alteration,                      
minimal  abnormality 
Grade 3:  Advanced sacroiliitis with erosions, widening, sclerosis or partial 
ankylosis 
Grade 4:  Total ankylosis 
Magnetic Resonance Imaging: It can detect early cartilage abnormalities and 
bone marrow oedema. 
Other investigations to find the systemic manifestations include: 
Cardiac: 
 Chest X Ray       –  May show cardiomegaly. Aortic regurgitation and mitral 
regurgitation occurring in ankylosing spondylitis can be associated with Left 
ventricular hypertrophy  and enlargement of other cardiac chambers. 
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Figure 8: Chest X Ray Showing cardiomegaly in aortic regurgitation 
ECG                   –  Cardiac conduction disturbances especially atrioventricular 
blocks can be detected. Most common is the first degree AV block. 
 
 
Figure 9: ECG with First degree AV Block 
 
 
Figure 10: ECG with Second degree AV Block (Type 1) 
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Figure 11: ECG with Second degree AV Block (type 2) 
  
    
         
 
Figure 12: ECG with Third degree AV Block 
 
Echocardiogram –  Can detect reguritant lesions, left ventricular 
hypertrophy, aortic root dilatation, left ventricular diastolic dysfunction, 
regional wall motion abnormalities in case of ankylosing spondylitis. Most 
common is the aortic regurgitation which can be mild, moderate, severe 
according to central jet velocity, Regurgitant orifice area, regurgitant fraction 
described later. 
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Figure 13: Echocardiogram in Aortic Regurgitation 
            
 
 
Figure 14: Aortic root dilatation 
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Pulmonary: 
Chest X Ray                      -  Apical fibrosis can be detected 
HRCT Chest                     –  Reveals if any interstitial lung disease 
Pulmonary Function test  –   Shows restrictive pattern of lung disease  
 
 
Figure 15: CT Chest with Bilateral upper lobe fibrosis 
                         
Ophthalmic examination, Renal parameters, relevant neurological 
investigations should be done in cases of eye, renal, neurological 
manifestations respectively. Duodenoscopy and colonoscopy in cases of 
suspected inflammatory bowel disease. 
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Diagnostic criteria:  
The Assessment of SpondyloArthritis International Society (ASAS)  criteria: 
Table 1: ASAS CRITERIA 
 
 
The characteristics of inflammatory back pain in AS are insidious onset of pain 
with onset in <40 years of age, which is improved with exercise and not so 
with rest, morning stiffness>30 minutes and pain more during night with 
alternating buttock pain. 
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Table 2: MODIFIED NEW YORK CRITERIA(1984) 
 
 
Grades of sacroiliitis  have been described earlier. 
 
The other criterias which were in use for ankylosing spondylitis were  
European Spondyloarthritis Study Group (ESSG) Criteria,  ROME Criteria  
and Amor Criteria. 
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Differential Diagnosis    
The diagnosis of AS can be confirmed by the ASAS criteria as described 
earlier. AS belongs to the group of diseases called Spondyloarthropathies 
(SpA), which have the inflammatory back pain as a common feature.  
Other types of Spondyloarthropathies  include psoriatic arthritis, 
reactive arthritis, inflammatory bowel disease (IBD), juvenile 
spondylarthropathy  and  group of undifferentiated spondyloarthropathies. The 
majority of affected individuals with SpA possess the HLA-B27 antigen.   
Psoriatic arthritis occurs in 5-7% of the people with psoriasis. The 
psoriatic arthritis  presents as a monoarthritis or oligoarthritis resembling the 
reactive arthritis pattern, or as an symmetrical polyarthritis like rheumatoid 
arthritis (RA), but with involvement of the DIP-joints in stead of the PIP-joints 
in RA and without a positive rheumatoid factor.   Axial disease occurs in about 
5% of the psoriasis patients. Axial involvement may occur independent from 
peripheral arthritis and is often  asymptomatic, but symptoms of  inflammatory 
back pain or chest wall pain may be present. Sacroiliitis is observed in one-
third of the patients and frequently asymmetric. Spondylitis may occur without 
sacroiliitis and may result in fusion of the spine. Enthesitis is common, 
especially in the oligoarticular form of the disease.  The radiographic features 
of the spine in case of psoriatic spondylitis show more or less random  
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syndesmophyte formation, whereas in AS, syndesmophytes form in a more 
ascending fashion
27
.   
Peripheral arthritis occurs in 10-20% of patients with IBD like ulcerative 
colitis and Crohns disease.Knees, ankles and feet are most frequently  involved.  
Large-joint effusions, especially of the knee are common. In 10% of the 
patients with IBD sacroiliitis or spondylitis occur and is often asymptomatic. 
The course of the spondylitis is independent  of the active bowel inflammation.   
Reactive arthritis refers to a mono-or oligoarthritis, which occurs after 
an infection of the genitourinary (with Chlamydia trachomatis), gastrointestinal 
tract (with Salmonella, Shigella, Yersinia or Campylobacter bacteria) or 
sometimes after a respiratory infection with Chlamydia pneumoniae. The 
arthritis usually occurs two to four weeks after the primary infection, as an 
urethritis or a period of diarrhoea. Conjunctivitis, with crusting of the eyelids in 
the morning,  can accompany the urethritis, but an acute anterior uveitis might 
also occur. The combination of arthritis, conjunctivitis and urethritis is also 
known as the Reiters syndrome.  The joint involvement is asymmetrical and 
located predominantly in the knees, ankles, and small joints of the feet, but 
joints of the upper extremities (wrist, elbows and hand joints) can also be 
affected. The large joints show signs of synovitis whereas the small joints of 
the hands and feet present as sausage digits or dactylitis. The course of reactive 
arthritis is self limiting with 3 to 12 months in the majority of the patients and 
the treatment consists of  Non-steroidal anti-inflammatory drugs (NSAIDs) 
whereas antibiotic treatment is not indicated.   
35 
 
Rheumatoid arthritis (RA) can manifest with an mono-or oligo-articular 
onset, but has most often a symmetrical polyarthritis. RA can be distinguished 
from AS by the absence of inflammatory back pain and the presence of  the 
positive rheumatoid factor, in 60-70% of the patients and because it is more 
often associated with an increased ESR or CRP. The radiological features of 
RA, with erosions of the small joints of hands and feet, differ from AS.   
Juvenile spondylarthropathy applies to a diagnosis made before the age 
of 16 and belongs to the group of Juvenile Idiopathic Arthritis (JIA). Most 
patients are boys and HLA-B27 positive and the tests for the rheumatoid factor 
and anti-nuclear antibodies (ANA) are usually negative. The symptoms mainly 
involve arthritis of the large joints of the lower extremities, especially the hip 
joint, which predicts a severe course of the disease. Enthesitis is common, as 
well as lower back or buttock pain. Acute anterior uveitis occurs in 5-10% of 
the patients.  Plain radiographs of the sacroiliac joints and the lumbar spine 
often do not show abnormalities for many years. Treatment is based on 
NSAIDs and sulfasalazine is added in case of persistent arthritis.  Diagnosis 
resembling the complaints of AS are other syndromes or diseases that effect the 
spine, like a prolapsed intervertebral disc, fibromyalgia, spinal tumours, like 
chordoma or ependymoma, bone tumours, like osteoid osteoma, plasmacytoma, 
bone metastases or leukemic infiltration and infections of the spinal or 
sacroiliac joints like tuberculosis and brucellosis. Metabolic bone diseases like 
osteomalacia, hypophosphatemia and rickets can  also cause back pain. The 
noninflammatory back pain is, in most cases, aggravated by activity and 
36 
 
relieved by rest and is not associated with a limited chest expansion or a limited 
lateral flexion of the lumbar spine.   
Diffuse idiopathic skeletal hyperostosis (DISH or Forestier‟s disease) 
can resemble AS because of the stiffness of the spine due to hyperostosis of the 
anterior longitudinal ligaments and bony attachments of the tendons. 
Occasionally the SI-joints show hyperostotic changes resembling sacroiliitis, 
but in most cases of DISH this feature is absent. However, in contrast with AS, 
the onset of the disease is at a later age (over 50), there is no association with 
HLA-B27 and there are more flowing ligamentous ossifications but less 
syndesmophyte formations.  
Outcome of the disease: 
The disease outcome is favourable in many patients whereas in 
approximately one third of the patients end with disabling deformities. A few 
studies  have showed that the outcome of ankylosing spondylitis can be 
predicted by several disease characteristics during the first ten years of the 
disease.
28,29
. Predictors of a severe outcome are arthritis of the hip joint, an 
increased erythrocyte sedimentation rate, (ESR > 30mm/hr), peripheral arthritis 
and a juvenile onset (<16 years).  
The rate of radiological progression appears to be constant during the 
several decades of the disease duration and is not higher in the first decade as 
once previously thought. However, most patients who have mild spinal 
restriction after the first decade of their disease do not progress to severe spinal 
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involvement during later years. Because AS starts at a young age, the 
socioeconomic consequences are high. Apart from the physical complaints, 
many patients struggle with work disability. This subject was recently studied 
by Boonen in the Netherlands. The age and sex adjusted risk of work 
withdrawal was 3 times higher in AS compared with the figures of the general 
Dutch population.   
The stage of the disease at the time of diagnosis and the delay of 
appropriate treatment also influence the outcome of the disease. Women appear 
to have a later age of onset and a milder disease compared with men. The 
majority of AS patients possess the HLA-B27 antigen (> 95%), which is found 
to be associated with the onset of the disease. The relationship of  this antigen 
with disease severity is less known.   
In HLA-B27-negative patients a later age of onset, and less frequent 
occurrence of acute anterior uveitis and less familial aggregation was 
described
30
. Also, HLA-B27 homozygous individuals seem to develop a more 
severe disease compared with HLA-B27 heterozygotes. There are conflicting 
data regarding mortality in patients with AS. One population-based study, 
showed no difference in mortality between males with AS and the general male 
population
31
.  
Other studies indicated that mortality in AS patients seen at referral 
centers was higher than expected with standardized mortality ratio‟s (SMR) of 
approximately 1.7 (range 1.5-1.9). This might be due to a linear relation 
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observed between disease severity
32
 and mortality as well as associations found 
between disease duration and mortality
33
. Among older patients X-ray 
treatment, which was used until 1960, might be a factor in the increased 
mortality risk of 4.8 due to leukemia and other types of cancer among these 
patients.   
Treatment: 
Treatment for ankylosing spondylitis includes certain exercises, 
physiotherapy and medications. Although these measures offer no cure, the 
morbidities of the disease can be reduced. It mainly reduces the pain, stiffness, 
inflammation and deformities. 
Flexibility and strengthening exercises can control pain and maintain 
mobility and reduces the stiffness if done regularly. Deep breathing exercises 
can enhance the lung capacity. A physical therapist can  help  to use heat and 
cold to help control your pain and stiffness. Heat can help with relaxation and 
pain relief and cold can help reduce inflammation. 
Patients major complaint of pain can be relieved by medications like 
non – steroidal anti inflammatory drugs like Ibuprofen, Naproxen, Diclofenac. 
These drugs can reduce pain by decreasing the inflammation. Dosage should be 
monitored and lowest possible dose should be prescribed. Other pain relievers 
are Paracetamol, Codeine in severe cases. 
If  the symptoms are not controlled with these medications then Anti – 
Tumour Necrosis Factor (TNF) medications can be initiated. They work by 
39 
 
preventing TNF, which is a chemical produced by inflammed tissues and 
suppresses joint inflammation. These medications are given as injections and 
they are Adalimumab, Etanercept, Golimumab, Infliximab. These medications 
can interfere with the immune mechanisms and can cause serious infections. 
Nice Guidelines: 
The National Institute for Health and Care Excellence (NICE) has 
produced guidance about the use of anti-TNF medication for AS. 
NICE states that anti TNF medications may only be used if: 
 Ankylosing spondylitis diagnosis is confirmed. 
 The level of pain  after assessing twice 12 weeks apart has not 
improved. 
 The condition has not improved after testing with BASDAI twice,12 
weeks apart. 
 Four weeks of highest possible dose  of 2 or more NSAIDs have not 
reduced the symptoms. 
After 12 weeks of treatment with anti-TNF medication, the pain score 
and BASDAI will be tested again to see if the patients have  enough 
improvement to make continuing therapy worthwhile. If they have 
improvement of symptoms, treatment can be  continued and tested every 12 
weeks. 
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If there is no enough improvement after 12 weeks, the test can be 
repeated at a later date and these medications can be stopped if there is no relief 
of symptoms. 
Corticosteroids: 
These drugs have a powerful anti – inflammatory action. These drugs 
can be  injected directly into the inflamed  joint and  the joint should be made 
to rest  for upto 48 hours. It can be used as injection or tablet forms. 
It is  wise to have a corticosteroid injection up to three times in one year, 
with at least three months between injections in the same joint because of side 
effects such as: 
 infection with response to the drugs 
 Depigmentation of the skin 
 Rupture of the tendon near the joint  
Other drugs like Disease  Modifying Anti-Rheumatic Drugs(DMARDS) 
like Sulfasalazine and Methotrexate can be used to reduce pain and 
inflammation. 
Surgery: 
Surgery is not indicated in many people with ankylosing spondylitis.  
However, in cases where a joint has become severely damaged, joint 
replacement surgery may be recommended to improve pain and movement in 
the affected joint like hip, knee joint replacement. In some patients corrective 
surgeries of the spine may be required.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS & METHODS 
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METHODOLOGY: 
The study is undertaken on the patients approaching the outpatient 
department as well as the Inpatients of the Coimbatore Medical College 
Hospital, Coimbatore during the period of study (i.e. July 2015 to July 2016).   
A total of fifty (50) subjects who  had approached the Rheumatology 
Department in the Hospital, and having satisfied the  ASAS  criteria were 
selected for the study.  These patients were compared with another fifty (50) 
age and sex matched control group, who had come to the OP department for 
non-specific complaints.  The control group was selected on a random basis.   
SELECTION CRITERIA 
(a) Inclusion Criteria  
 Adult patients (both sex) between the age group of 18 to 60 
 Patients satisfying Assessment of Ankylosing Spondylitis 
International Society (ASAS) criteria  for Ankylosing Spondylitis 
 
(b)  Exclusion Criteria  
 Pregnant women 
 Minors (below the age of consent) 
 Persons suffering from congenital heart diseases  
 Persons suffering from Psoriatic Arthritis 
 Persons suffering from  Rheumatic valvular heart diseases  
 Persons not capable of giving consent (psychiatric patients) 
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 Persons unwilling to undergo the study (who refused to consent)  
TYPE OF STUDY 
Cross sectional study 
All patients are evaluated with: 
Detailed history 
Age, sex, duration of the disease, extra axial joint involvement, 
extraarticular manifestations, presence of other systemic diseases, response to 
anti inflammatory drugs, family history of ankylosing spondylitis were all 
documented. 
Examination 
Examination of all joints was done and cardiac examination was done to 
find for cardiomegaly, cardiac murmurs. Ophthalmic and other systemic 
examination was done. 
Investigations 
 Routine investigations like Blood haemoglobin, Renal function test and 
blood sugar estimation were done.  
C Reactive Protein was estimated using latex agglutination kit.  
Erythrocyte sedimentation rate was measured. 
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Radiography: 
X Ray  B/L sacroiliac joint:  
X Ray of peripheral joints were done. 
Chest X Ray PA view was done to  look for cardiomegaly 
  Electrocardiogram:  
A 12 lead electrocardiogram was taken for all the cases and controls. 
Atrio ventricular blocks were found out by looking at the PR intervals and the 
proceeding QRS complexes, Bundle branch block and fascicular block were 
interpreted by looking at the QRS complexes in the specific leads. Chamber 
hypertrophies were also noted. 
Echocardiogram: 
With the patient in supine and left lateral position using a Hewlett 
Packard Sonos 2500 scanning machine, M mode, 2 dimensional and Doppler 
echocardiography were performed. 
Cardiac position, cardiac chambers, Atrial and ventricular septae, 
valves, pericardium, great vessels, ejection fraction, peak velocities across the 
valves, trans valvular mean gradient,  grading of regurgitations and aortic root 
diameter  were noted. 
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Grading of Aortic Regurgitation (AR) by echocardiography is done according 
to the following measures: 
Parameters       Mild AR     Moderate AR     Severe AR 
Jet width <25% of LVOT 25 – 64% of 
LVOT 
≥65% of LVOT 
Vena contracta <0.3 cm 0.3 – 0.6 cm >0.6 cm 
RVol <30 ml/beat 30 – 59 ml/beat ≥60 ml/beat 
RF <30% 30% - 49% ≥50% 
ERO <0.10 sq.cm 0.10 – 0.29 sq.cm ≥0.3 sq.cm 
 
 
Grading of Mitral Regurgitation (MR) by echocardiography is done by the 
following measures: 
Parameters   Mild MR  Moderate MR   Severe MR 
Central jet <20% LA 20% - 40% >40% 
Vena contracta <0.3cm 0.4 – 0.7cm >0.7cm 
RVol - <60 ml ≥60 ml 
RF - <50% ≥50% 
ERO - <0.40 sq.cm ≥0.40 sq.cm 
 
 
 
Left ventricular diastolic dysfunction is assessed by Echocardiogram with peak 
Early (E) and Late (A) trans mitral filling velocities and their ratio (E/A).  
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Statistical analysis: 
The data were reported depending on their distribution as Mean +/- 
Standard deviation or the median. Between groups, the differences in 
quantitative variables were assessed by means of the unpaired t test. 
Comparsion between groups was made by the Non parameteric Mann - 
whitney test. Differences in categoric variables were assessed by Chi-square 
test between groups.  
A p value of <0.05 using a two-tailed test was taken as being of 
significance for all statistical tests. All data were analysed with a statistical 
software package (SPSS, version 16.0 for windows).  
 
 
 
 
 
 
 
                                   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATION  & RESULTS 
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OBSERVATION AND RESULTS 
The study is undertaken on the patients approaching the outpatient 
department of the Rheumatology department and in the inpatients of 
Coimbatore Medical College Hospital during the period of study (July 2015 to 
July 2016). A total of fifty patients who had satisfied the ASAS criteria were 
selected for the study. These patients were compared with another fifty control 
group who came to the  OP Department for non – specific complaints. The 
control group was selected on a random basis.  
Table 3: Mean age of cases and controls 
                                 
In the study group the mean age  group of patients with AS was 38.1 
years with a standard deviation of 3.1 years and that of the control group was 
38.3 years with standard deviation of 3.9 years. The youngest patient was 32 
years and oldest was 45 years among the study groups. 
 
 
Study  
Mean 
SD 
95% CI for 
Mean 
Minimum Maximum Groups [Years] Lower Upper 
Cases 38.1 3.1 37.2 39.0 33 44 
Control 38.3 3.9 37.2 39.4 32 45 
Total 38.2 3.5 37.5 38.9 32 45 
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Chart 1: Mean age of cases and controls 
 
Table 4:AGE DISTRIBUTION IN STUDY GROUPS 
                                            
 
           
 
 
 
 
 
 
      STUDYGROUP   
 AGE CASES CONTROL TOTAL (%) 
31- 35 12 15 27 27% 
36 – 40 25 19 44 44% 
41 -45 13 16 29 29% 
TOTAL 50 50 100   
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Chart 2: Age distribution in the study groups 
 
 
 
 
In both the cases and controls of the study groups, more number of 
people lie between the age group of 36 – 40 years. 50% of the cases and 38% 
of the controls lie in this age group. The remaining persons lie equally on either 
side in both the cases and the controls. 
 
 
                   
 
31- 35 36 - 40 41 -45
CASES 24% 50% 26%
CONTROL 30% 38% 32%
0%
10%
20%
30%
40%
50%
60%
Age Distribution with Study Group 
[N=100][p>0.05]
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Table 5: Gender Distribution in the Study Groups 
                                            
 
 
 
 
 
Chart 3: Gender distribution in the cases and controls 
 
        
Males are more commonly affected with Ankylosing Spondylitis with 
39 male cases (78%) and 11 female cases(22%). Control group also have a 
more number of males with 35 males and 15 females.  
 
MALE FEMALE
CASES[n=50] 78% 22%
CONTROL[n=50] 70% 30%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
      STUDYGROUP   
GENDER CASES CONTROL TOTAL (%) 
MALE 39 35 74 74% 
FEMALE 11 15 26 26% 
TOTAL 50 50 100   
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Table 6: Duration of disease(AS) in cases 
 
Duration n (%) 
1- 3 yrs 12 24% 
4-6 yrs 25 50% 
7-11 yrs 13 26% 
Total 50 100% 
 
Chart 4: Duration of disease (AS) in cases 
 
 
The duration of the disease varies between 1 and 11 years. Half of the 
cases lie within the duration of 4-6 years (50%). The remaining half is nearly 
equally shared by the duration of disease of 1-3 years(24%) and 7-11(26%) 
years. 
1-3 yrs
24%
4-6 yrs
50%
7-11 yrs
26%
Duration of Disease in 
Cases  [n=50]
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Table 7:Cardiac manifestations in study groups 
Cardiac STUDYGROUP     
Manifestation CASES CONTROL TOTAL (%) 
With 11 2 13 13% 
Without 39 48 87 87% 
TOTAL 50 50 100   
 
Chart 5: Cardiac manifestations in study groups 
 
 
Cardiac manifestations in number of cases and controls revealed that the 
manifestations occurred in 11 (22%) out of 50 cases and 2 out of 50 controls 
(4%) in the study group.  
 
 
 
With Without 
CASES[n=50] 22% 78%
CONTROL[n=50] 4% 96%
0%
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40%
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80%
100%
120%
Cardiac Manifestation 
[N=100][p<0.05]
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Table 8:.Age in relation to the cardiac manifestations in the study groups 
 
Chart 6: Age in relation to the cardiac manifestations in the study groups 
 
 
 
 
 
  Cardiac Manifestations     
STUDYGROUP Age With Without Total (%) Sig 
CASES 
 
 
 
CONTROLS 
31- 35 0 12 12 24%   
36 - 40 3 22 25 50% <0.05 
41 -45 8 5 13 26%   
Total 11 39 50 100%   
   31 - 35 0 15 15 30% 
 36 - 40 1 18 19 38% >0.05 
41 -45 1 15 16 32%   
Total 2 48 50 100%   
31- 35 36 - 40 41 -45 31- 35 36 - 40 41 -45
CASES CONTROL
CM With [n=11] 0% 27% 73% 0% 50% 50%
CM Without [n=39] 31% 56% 13% 31% 38% 31%
0%
10%
20%
30%
40%
50%
60%
70%
80%
Association of Age with Cardiac 
Manifestation [N=100][p<0.05]
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 When the occurrence of  cardiac manifestations in AS were divided 
according to the age among the cases, it was found that 73% of cardiac 
manifestations were found in the age group of 41 – 45 years, 27% in the age 
group of 36 – 40 years and none in the age group of 31 -35 years. This showed 
that Cardiac manifestations occurs with increasing age with a statistical 
significance (P>0.05) whereas it is not so in the control group.   
 
 
Table 9: Gender in relation to Cardiac Manifestations in study Groups 
       
    
Cardiac 
Manifestations     
STUDYGROUP Gender With Without Total (%) Sig 
CASES 
Male 9 30 39 78%   
Female 2 9 11 22% >0.05 
Total 11 39 50 100%   
CONTROL 
Male 2 33 35 70%   
Female 0 15 15 30% 
 Total 2 48 50 100%   
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Chart 7: Gender in relation to Cardiac Manifestations in study Group 
 
 
 
 
 
 In the association of gender with cardiac manifestations it was found 
that males (82%) are more commonly involved than the females (18%) among 
the cases in the study group 
  
Male Female Male Female
CASES CONTROL
CM With [n=11] 82% 18% 100% 0%
CM Without [n=39] 77% 23% 69% 31%
0%
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40%
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80%
100%
120%
Association of Gender with Cardiac 
Manifestation [N=100][p>0.05]
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Table 10. Duration of Disease(AS ) in relation to Cardiac Manifestations in 
study Groups 
 
Chart 8: Duration of Disease(AS ) in relation to Cardiac Manifestations in 
study Groups 
 
 
 Longer duration of the disease was significantly associated with the 
occurrence of cardiac manifestations with 91% in those with the duration 
between 7-11 years, 9% in those between 4-6 years and none among those with 
duration of AS < 4 years which was statistically highly significant. 
STUDYGROUP Duration With Without Total (%) Sig 
CASES 
0- 3 yrs 0 12 12 24%   
4-6 yrs 1 24 25 50% <0.001 
7-11 yrs 10 3 13 26%   
Total 11 39 50 100%   
0- 3 yrs 4-6 yrs 7-11 yrs
CASES
CM With [n=11] 0% 9% 91%
CM Without [n=39] 31% 62% 8%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Association of Duration of Disease with 
Cardiac Manifestation [N=100][p<0.001]
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Table 11: Number of Positive Clinical Parameters in relation to Cardiac 
Manifestations in study Groups 
  No of Cardiac Manifestations     
  STUDYGROUP clinical  With Without Total (%) Sig 
  
CASES 
2 1 13 14 28%   
  3 9 18 27 54% >0.05 
  4 1 8 9 18%   
  Total 11 39 50 100%   
   
Chart 9: Number of Positive Clinical Parameters in relation to Cardiac 
Manifestations in study Groups 
 
 
 
 
  
 
The number of clinically positive parameters of AS in cases with and without 
cardiac manifestations is not statistically significant. 
2 3 4
CASES
CM With [n=11] 9% 82% 9%
CM Without [n=39] 33% 46% 21%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Association of Positive clinical 
parameters with Cardiac 
Manifestation [N=100][p>0.05]
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Table 12:Grading by X ray imaging in relation to Cardiac Manifestations 
in study Groups 
 
X ray Cardiac Manifestations     
  STUDYGROUP Grading With Without Total (%) Sig 
  
CASES 
2 B/L  1 10 11 22%   
  3 U/L  4 17 21 42%   
  3 B/L  3 4 7 14%   
  4 U/L  2 7 9 18% >0.05 
  4 B/L  1 1 2 4%   
  Total 11 39 50 100%   
   
Chart 10: Grading by X ray imaging in relation to Cardiac Manifestations 
in study Groups 
 
 
 
 
 
 
 
 Cardiac manifestations in association with X Ray imaging by grading of 
sacroiliitis in AS is not found to be statistically significant. 36% of the cases 
with cardiac manifestations have 3 unilateral grading which is more than that of 
3 bilateral, 4 unilateral and 4 bilateral. 
2 B/L 3 U/L 3 B/L 4 U/L 4 B/L 
CASES
CM With [n=11] 9% 36% 27% 18% 9%
CM Without [n=39] 26% 44% 10% 18% 3%
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
Association of  Xray Grading with 
Cardiac Manifestation [N=100][p>0.05]
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Table 13: Cardiac Symptoms in relation to Cardiac Manifestations in 
study Groups 
  Cardiac Cardiac Manifestations     
 STUDYGROUP Symptoms With Without Total (%) 
  
CASES 
YES 3 0 3 6%   
 NO 8 39 47 94% 
  Total 11 39 50 100%   
 CONTROLS        NO 2 48 50 100%   
        Total 2 48 50 100%  
  
Chart 11: Cardiac Symptoms in relation to Cardiac Manifestations in 
study Groups 
 
 Cardiac symptoms were found in 27% of the cases with cardiac 
manifestations and not found in 73% of the cases with cardiac manifestations. 
 
Cardiac 
Symptoms 
Yes [n=3]
Cardiac 
Symptoms 
No[n=47]
Cardiac 
Symptoms 
No[n=50]
CASES CONTROL
CM With 27% 73% 4%
CM Without 0% 100% 96%
0%
20%
40%
60%
80%
100%
120%
Association of  Cardiac Symptoms with 
Cardiac Manifestation [N=100][p<0.05]
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Table 14: Chest X ray in relation to Cardiac Manifestations in study 
Groups 
  Chest  
Cardiac 
Manifestations     
  STUDYGROUP X ray With Without Total (%) 
   
CASES 
Cardiomegaly 3 0 3 6%   
  Normal  8 39 47 94% 
   Total 11 39 50 100%   
  
CONTROLS 
Normal  2 48 50 100%   
  Total 2 48 50 100%   
   
Chart 12: Chest X ray in relation to Cardiac Manifestations in study 
Groups 
 
 Chest X Ray showed cardiomegaly in 27% of the cases with cardiac 
manifestations and was normal in 73% of the cases with cardiac manifestations. 
Cardiomegaly[n=3] Normal [n=47] Normal [n=50]
CASES CONTROL
Cardiac Manifestations 
With
27% 73% 100%
Cardiac Manifestations 
Without
0% 100% 100%
0%
20%
40%
60%
80%
100%
120%
Association of  Cardiac chest X ray with 
Cardiac Manifestation [N=100][p<0.05]
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Table 15: ECG in relation to Cardiac Manifestations in study Groups 
    
Cardiac 
Manifestations     
STUDYGROUP ECG With Without Total (%) Sig 
CASES 
Abnormal 8 0 8 16% <0.01 
Normal 3 39 42 84%   
Total 11 39 50 100%   
CONTROL 
Abnormal 1 0 1 2%   
Normal 1 48 49 98% >0.05 
Total 2 48 50 100%   
 
 
Chart 13: ECG in relation to Cardiac Manifestations in study Groups 
 
 
  
Abnormal Normal Abnormal Normal
CASES CONTROL
Cardiac 
Manifestations 
With [n=11]
73% 27% 50% 50%
Cardiac 
Manifestations 
Without [n=39]
0% 100% 0% 100%
0%
20%
40%
60%
80%
100%
120%
Association of  ECG with Cardiac 
Manifestation [N=100][p<0.05]
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 ECG was found to be abnormal in 8 out of 11 cases (73%) and normal 
in 3 out of 11 cases (27%) with cardiac manifestations whereas it was abnormal 
in 1 out of 2 controls with the cardiac manifestations which was statistically 
highly significant (P<0.01).  
 
Table 16: ECG abnormalities in cases with cardiac manifestations 
 
  
Cardiac 
Manifestations       
       ECG With Without Total (%) Sig 
       Degree AV Block - 1 2 0 2 4%   
       Degree AV Block - 2 1 0 1 2%   
       LBBB 1 0 1 2%   
       LVH  3 0 3 6% <0.01 
       LAFB  1 0 1 2%   
       Normal  3 39 42 84%   
       Total 11 39 50 100%   
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Chart 14: ECG abnormalities in cases with cardiac manifestations 
 
 
 
 ECG among the cases with cardiac manifestations showed conduction 
disturbances (45%) and left ventricular hypertrophy (27%) and normal(27%). 
The conduction disturbances noted were first and second degree Atrio-
ventricular block, left anterior fascicular block, left bundle branch block. 
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1
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100%
120%
Association of  ECG with Cardiac Manifestation 
[N=100][p<0.015]
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Table 17: ECG abnormalities in cases and controls with cardiac 
manifestations 
 
  Cardiac Manifestations     
STUDYGROUP ECG With Without Total (%) Sig 
CASES 
Degree AV Block 
- 1 2 0 2 4%   
Degree AV Block 
- 2 1 0 1 2%   
LBBB 1 0 1 2%   
LVH  3 0 3 6% <0.01 
LAFB  1 0 1 2%   
Normal  3 39 42 84%   
Total 11 39 50 100%   
CONTROL 
LAFB  1 0 1 2%   
Normal  1 48 49 98% >0.05 
Total 2 48 50 100%   
 
 
Various ECG changes among the cases with cardiac manifestations was 
compared with that among the controls which was statistically significant 
shown in the table above and the chart below. 
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Chart 15: ECG abnormalities in cases and controls with cardiac 
manifestations 
 
 
Table 18: ECHO in relation to Cardiac Manifestations in study Groups 
 
Degree AV 
Block - 1
Degree AV 
Block - 2
LBBB LVH LAFB Normal LAFB Normal 
CASES CONTROL
Cardiac Manifestations With 18% 9% 9% 27% 9% 27% 50% 50%
Cardiac Manifestations Without 0% 0% 0% 0% 0% 100% 0% 100%
0%
20%
40%
60%
80%
100%
120%
Association of  ECG with Cardiac Manifestation [N=100][p<0.05]
    
Cardiac 
Manifestations     
STUDYGROUP ECHO With Without Total (%) Sig 
CASES 
Abnormal 6 0 6 12% <0.01 
Normal 5 39 44 88%   
Total 11 39 50 100%   
CONTROL 
Abnormal 1 0 1 2%   
Normal 1 48 49 98% >0.05 
Total 2 48 50 100%   
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Chart 16: ECHO in relation to Cardiac Manifestations in study Groups 
 
 
 
 
 Echocardiographic was found to be abnormal in 6 out of 11 cases (55%) 
and normal in 5 out of 11 cases (45%) with cardiac manifestations whereas it 
was abnormal in 1 out of 2 controls with the cardiac manifestations. The 
association was statistically highly significant (P<0.01) . 
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Table 19: Echocardiographic abnormalities in cases with Cardiac 
Manifestations 
  
Cardiac 
Manifestations       
  ECHO With Without Total (%) Sig 
  Mild AR  1 0 1 2%   
  Moderate AR  2 0 2 4%   
  Severe AR 1 0 1 2%   
  Aortic Root Dilated  1 0 1 2% <0.01 
  Moderate MR 1 0 1 2%   
  Normal  5 39 44 88%   
  Total 11 39 50 100%   
   
Chart 17: Echocardiographic abnormalities in cases with Cardiac 
Manifestations 
 
 
Mild AR 
Moderate 
AR 
Severe AR
Aortic Root 
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[N=100][p<0.01]
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 Echocardiographic findings among the cases with cardiac manifestations 
showed Aortic regurgitation  (36%) and Isolated Aortic root dilatation (9%) 
and Mitral regurgitation (9%). Aortic regurgitation was mild in 9%, moderate 
in 18%, severe in 9% among the cases with cardiac manifestations. Aortic root 
dilatation was associated with aortic regurgitation in 2 of the cases. 
  
Table 20: Echocardiographic abnormalities in cases and controls with 
Cardiac Manifestations 
    
Cardiac 
Manifestations     
 STUDYGROUP Echo With Without Total (%) Sig 
 
CASES 
Mild AR  1 0 1 2%   
 Moderate AR  2 0 2 4%   
 Severe AR 1 0 1 2%   
 Aortic Root 
Dilated  1 0 1 2% <0.01 
 Moderate MR 1 0 1 2%   
 Normal  5 39 44 88%   
 Total 11 39 50 100%   
 
CONTROL 
GR 1 LVDD 1 0 1 2%   
 Normal  1 48 48 96% >0.05 
 Total 2 48 50 100%   
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Chart 18: Echocardiographic abnormalities in cases and controls with 
Cardiac Manifestations 
 
 
 
Various Echocardiographic changes among the cases with cardiac 
manifestations was compared with that among the controls which was 
statistically significant. (P<0.05). 
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Moderate MR Normal GR 1 LVDD Normal 
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Association of  ECHO with Cardiac Manifestation 
[N=100][p<0.01]
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Table 21:Mean Clinical Variables in cases in relation to cardiac 
mmanifestations 
  Cardiac 
Manifestation 
Mean SD 
95% CI for 
Mean 
Minimum Maximum Sig   Lower Upper  
Age WITH 41.45 1.695 40.32 42.59 38 44   
WITHOUT 37.15 2.749 36.26 38.04 33 44 <0.001 
Total 38.1 3.112 37.22 38.98 33 44   
Duration WITH 8.36 1.502 7.35 9.37 6 11   
WITHOUT 4.33 1.675 3.79 4.88 1 8 <0.001 
Total 5.22 2.341 4.55 5.89 1 11   
CRP WITH 13.36 5.784 9.48 17.25 8 28   
WITHOUT 16.72 6.836 14.5 18.93 5 30 >0.05 
Total 15.98 6.711 14.07 17.89 5 30   
          
 
Mean of clinical variables 
Age   41+/-1.7   37+/-2.7   <0.001 
              
Duration of Disease 8.4+/-1.5   4.3+/-1.7   <0.001 
              
CRP [mg/dl] 13.4+/-5.8 16.7+/-6.8   >0.05 
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This table shows mean clinical variables – age of the cases, duration of 
the disease, CRP among the cases with and without cardiac manifestations and 
their statistical significance. Age and duration of the disease is statistically 
significant whereas CRP is not significant statistically in relation to cases with 
and without cardiac manifestations. 
Chart 19: Mean age in cases with and without cardiac manifestations 
 
 
 
 This box plot chart shows that the mean age of the cases with cardiac 
manifestations is 41.45 with a standard deviation (SD) of 1.695 (40.32 to 
42.59) and range from 38 to 44 years and those without cardiac manifestations 
with mean of 37.15, SD of 2.749 (36.26 to 38.04) and range from 33 to 44 
years. This shows statistical significance of P< 0.001  
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Chart 20: Mean CRP value in cases with and without cardiac 
manifestations 
 
 
 
 This box plot chart shows that the CRP of the cases with cardiac 
manifestations has a mean value of 13.36 with a standard deviation (SD) of 
5.784 (9.48 to 17.25) and range from 8 to 28 mg/dl and those without cardiac 
manifestations shows a mean of 16.72, SD of 6.836 (14.5 to 18.93) and range 
from 5 to 30 mg/dl. This  association is not statistically significant (P>0.05). 
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Chart 21: Mean duration of cases with and without cardiac manifestations 
 
 
 
 This box plot chart shows that the mean duration of the cases with 
cardiac manifestations is 8.36 years with a standard deviation (SD) of 1.502 
(7.35 to 9.37) and range from 6 to 11 years and those without cardiac 
manifestations has a  mean of 4.33, SD of 1.675(3.79 to 4.88) and range from 1 
to 8 years. This shows statistical significance of P< 0.05 
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SUMMARY DATA 
Table 22: Association of clinical variables with Cardiac Manifestation in cases 
and their statistical significance   
    Cardiac Manifestations         
    
With 
[n=11]   
Without 
[n=39]         
Age                 
31- 35   0%   31%         
36 – 40   27%   56%   <0.05     
41 -45   73%   13%         
Gender                 
Male   82%   77%         
Female   18%   23%   >0.05     
Duration of Disease(AS) in years           
0- 3 yrs   0%   31%         
4-6 yrs   9%   62%   <0.001     
7-11 yrs   91%   8%         
No.of positive clinical parameters           
2   9%   33%         
3   82%   46%   >0.05     
4   9%   21%         
Grading of AS  by X Ray imaging           
2 B/L    9%   26%         
3 U/L    36%   44%         
3 B/L    27%   10%   >0.05     
4 U/L    18%   18%         
4 B/L    9%   3%         
ECG                 
Degree AV Block – 1 18%   0%         
Degree AV Block – 2 9%   0%         
LBBB   9%   0%   <0.01     
LVH    27%   0%         
LAFB    9%   0%         
Normal    27%   100%         
ECHO                 
Mild AR    9%   0%         
Moderate AR  18%   0%         
Severe AR 9%   0%         
Aortic Root Dilated  9%   0%   <0.01     
Moderate MR 9%   0%         
Normal    45%   100%         
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 Thus when cases with and without cardiac manifestations were 
compared, a significant statistical correlation was found with Age, Duration of 
the disease, ECG findings and Echocardiography and not so with Sex, Number 
of positive clinical parameters present in relation to the disease, Grading of 
sacroiliitis in AS by X Ray imaging.   
 
Table 23:ECG and ECHO abnormalities in cases and controls and their 
statistical significance 
    STUDY GROUP           
    CASES [n=50]   
CONTROL 
[n=50]         
         ECG         
Abnormal     16%   2%         
Normal       84%   98%   <0.05     
ECHO                 
Abnormal     12%   2%         
Normal       88%   98%   <0.05     
 
 The association is statistically significant when the ECG and 
Echocardiographic findings are compared among the cases and controls. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
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DISCUSSION: 
 Cardiac involvement is a well documented extraarticular manifestation 
among the patients suffering from ankylosing spondylitis. These abnormalities 
have been documented in several studies using echocardiography, 
electrocardiography. 
 In this study cardiac conduction abnormalities and valvular 
abnormalities were seen in 11 patients with ankylosing spondylitis. Among 
them cardiac conduction abnormalities were seen in 5 (10%), aortic 
regurgitation in 4(8%), Isolated aortic root dilatation(2%), mitral 
regurgitation(2%). Cardiac conduction abnormalities seen were first degree 
heart block (4%), second degree heart block (2%), left anterior fascicular 
block(2%), left bundle branch block(2%). Aortic regurgitation was mild in 2%, 
moderate in 4%, severe in 2%. 4% of AR were associated with aortic root 
dilatation. 
Age and sex distribution: 
The mean age of patients with ankylosing spondylitis was 38.1 years 
and that of the controls was 38.3 years. The age of the patients in the  study 
group ranged from 31 – 45 years. The maximum prevalence of cardiac 
manifestations was between 41 – 45 years among the cases.  Mean age of cases 
with cardiac manifestations was 41.45 years. Asociation of age of the cases 
with and without cardiac manifestations is statistically significant (P<0.05) 
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The study has 50 cases and 50 controls among which 39 are male cases 
and 11 are female cases and 35 are male controls with 15 of female controls. 
The male to female ratio in the cases was 3.5:1, in which cadiac manifestations 
occurred in 9 male caases and 2 female cases. Cardiac  abnormalities occurred 
in 2 male controls. 
S.Sukenik et al, 
35  
made a study with 40 patients with a mean age of the 
cases being  44.6 years, with 37 male cases and 3 female cases. The mean age 
of these patients was slightly higher than in our study. 
Duration of Ankylosing Spondylitis: 
In this study there were significantly higher prevalence of cardiac 
involvement in patients with increased duration of ankylosing spondylitis.The 
duration of the disease in the cases varied from 1 – 11 years. Higher prevalence 
of cardiac manifestations occurred between the duration of 7 – 11 years(91%). 
The mean duration of disease in patients with cardiovascular manifestations 
was 8.36 years. This had statistiscally significant correlation when compared 
with patients with  and without cardiac manifestations (P<0.001). 
O,Neill.T.W.et al, 
34
conducted study in twenty four patients with a 
disease duration of more than or equal to ten years and found cardiac 
abnormalities in 29% of the cases. 
Roldan et al, 
36 
conducted a study on cardiovascular manifestations in 
cases suffering from ankylosing spondylitis and found that the association was 
increased with increased duration of the disease. 
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Number of positive clinical parameters, severity of ankylosing 
spondylitis by X Ray grading, C- Reactive protein,  all these parameters had no 
significant correlation with the occurrence of cardiac manifestations in patients 
with ankylosing spondylitis (P>0.05) 
Roldan et al, 
36
 in the study had described that cardiac manifestations in 
patients with ankylosing spondylitis was unrelated to the disease activity, 
severity. 
Electrocardiogram: 
In the study, 16% of the cases had electrocardiographic changes among 
which 10% had conduction abnormalities in the form of first degree heart 
block, second degree heart block, left bundle branch block and left anterior 
fascicular block. 6% of the cases had left ventricular hypertrophy according to 
Romhilt Estes criteria. 2% of the controls had left anterior fascicular block. The 
association of electrocardiographic manifestations in the cases with and 
without cardiac manifestations was statistically significant (P<0.01) and also 
that between the cases and controls (P<0.05) 
Helena Forsblad-d‟Eliaet al, 37 in the study found that 10-33% of 
patients with ankylosing spondylitis had conduction disturbances , mostly of 
first degree atrioventricular block, complete bundle branch blocks. 
S.Sukenik et al, 
35
 in the study conducted in forty patients found out that 
eight patients(20%), had conduction disturbances in the form of atrioventricular 
block and bundle branch block. 
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O, Neill et al, 
34
 in the study conducted in twenty four patients with 
ankylosing spondylitis found that  significant 10% of the cases had conduction 
abnormalities. 
Echocardiogram: 
 In the study 12% of the cases were with echocardiographic 
abnormalities among which 8% of the patients had aortic regurgitation, 2% had 
mitral regurgitation, 2% had isolated aortic root dilatation and 4% aortic 
regurgitation was associated with aortic root dilatation. This had statistically 
significant association in the cases with and without cardiac 
manifestations(P<0.01)  and that between the cases and the controls(P<0.05). 
O.Neill T.W. et al, 
34 
in the study of twenty four patients found that two 
patients had aortic regurgitation(8%). 
Several studies had found the prevalence of aortic regurgitation to be 
high in patients with ankylosing spondylitis when the patients are subjected to 
trans oesophageal echocardiography rather than transthoracic echocardiography 
and also early valvular changes have been found with transoesophageal 
echocardiography, as done by  Roldan et al.
36 
The prevalence of cardiovascular abnormalities in the present study 
would have been higher if transesophageal echocardiography has been done 
and if the duration of ankylosing spondylitis in the cases had been longer. 
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CONCLUSION: 
 Cardiovascular manifestations in ankylosing spondylitis were seen in 11 
out of 50 cases. Maximum prevalence occurred in the age group of 41-
45 years with a male to female ratio of 3.5:1.Mean age of the cases with 
cardiovascular abnormalities was found to be 41.45 years. 
 Duration of ankylosing spondylitis among the cases in the study group 
varied between 1 – 11 years. The maximum prevalence of 
Cardiovascular manifestations in AS occurred in patients with increased 
duration of the disease. Mean duration of the diease associated with 
cardiovascular manifestations was found to be 8.36 years. 
 No significant correlation was found in association with sex, increased 
number of positive clinical parameters to the occurrence of 
cardiovascular manifestations in ankylosing spondylitis. 
 Increase in C-Reactive protein, grading of sacroiliitis by X Ray, cardiac 
symptoms in AS, Chest X Ray also were not found to be significantly 
associated with the cardiovascular manifestations. 
 Three patients had cardiomegaly (6%) in the chest X Ray and those 
patients had cardiac symptoms like chest pain and breathlessness. 
 The electrocardiogram revealed significant cardiac conduction 
abnormalities (10%) and left ventricular hypertrophy(6%) among the 
cases. Conduction abnormalities were first degree AV block (4%), 
second degree AV block(2%), left anterior fascicular fascicular 
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block(2%), left bundle branch block (2%) whereas only 2% of control 
subjects had conduction abnormalities in ECG, left anterior fascicular 
block. 
 The echocardiographic abnormalities were found in 12%  of the cases 
which had significant association in patients with AS. Most common 
abnormality found among AS patients were aortic regurgitation (8%) 
[Mild – 2%, Moderate – 4%, severe – 2%]. One case had moderate 
mitral regurgitation (2%) and one another had aortic root dilatation(2%) 
with 4% aortic regurgitation associated with aortic root dilatation. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
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SUMMARY: 
 The study was conducted in 50 cases, the patients suffering from 
ankylosing spondylitis who had attended the outpatient and Inpatient  
departments at the Coimbatore medical college hospital and 50 controls who 
were selected on a random basis. The association of cardiovascular 
manifestations with the disease were found among the cases and various factors 
of the disease influencing the manifestations were studied and they were 
compared with the control group. 
 Cardiovascular abnormalities are important extraarticular 
manifestations in patients with ankylosing spondylitis. These 
abnormalities can be clinical or sub clinical. 
 When patients with ankylosing spondylitis were evaluated, 11(22%) out 
of 50 patients had some  form of cardiovascular abnormalities.Out of 
this 10% had conduction abnormalities in electrocardiogram and 10% 
had valvular regurgitation, 2% had isolated aortic root dilatation  by 
echogardiography. Among these 4% of aortic regurgitation was 
associated with aortic root dilatation. 
 Most common was aortic regurgitation among the valvular 
diseases(8%), other was mitral regurgitation and  Isolated aortic root 
dilatation. Common conduction disturbance was first degree AV block.  
 The maximum prevalence of cardiac abnormalities were found between 
the age group of 41-45 years indicating that as the age goes on, the 
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prevalence of cardiac manifestations increase. Male to female ratio of 
3.5:1 with more incidence among the males. 
 High prevalence of cardiac involvement occurred in patients with 
increased duration of the disease ranging from 7 – 11 years with a mean 
duration of disease being 8.36 years. 
 Statistically significant association of the cardiovascular manifestations 
occurred with increase in the age, duration of the disease. 
 No significant association was found with the gender, increase in the 
number of positive clinical parameters of the disease, increase in C- 
Reactive Protein, grading of sacroiliitis by X Ray imaging, CXR, 
Cardiac symptoms  in ankylosing spondylitis. 
 Thus the conduction disturbances in electrocardiography and valvular 
lesions and aortic root dilatation in echocardiography among the cases 
were statistically significant when compared with the controls. 
 Since cardiovascular abnormalities are one of the most common cause 
of mortality in patients with ankylosing spondylitis, these should be 
detected early and thereby it will assess in the proper management of 
the patients with the disease at the appropriate time. 
 Therefore it is mandatory that every patient with ankylosing spondylitis 
should undergo cardiac evaluation to help in early detection and 
treatment of cardiovascular abnormalities, to reduce the morbidity and 
mortality associated with the disease and to improve the quality of life 
of patients with ankylosing spondylitis. 
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ANNEXURES 
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PROFORMA: 
NAME:                                 AGE/SEX:                       OP/IP NO: 
 
ADDRESS: 
 
HISTORY: 
 
ANKYLOSING SPONDYLITIS: 
ARTICULAR SYMPTOMS: 
Duration of back pain: 
Duration of morning stiffness: 
Number of extra axial joints involved: 
 
EXTRAARTICULAR SYMPTOMS: 
Malaise, fatigue, low grade fever 
Cough, Chest pain 
Dyspnoea, giddiness 
Swelling of legs 
Ocular symptoms 
Skin lesions 
Muscle weakness 
Bladder and bowel habits 
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FAMILY HISTORY OF ANKYLOSING SPONDYLITIS: 
 
TREATMENT HISTORY: 
Pain relief with response to NSAIDs and treatment with other drugs. 
 
PHYSICAL EXAMINATION: 
GENERAL EXAMINATION: 
Pulse:           Blood pressure: 
Pallor/clubbing/cyanosis 
Pedal oedema/icterus/lymphadenopathy 
Ocular and dermatological examination 
 
SYSTEMIC EXAMINATION: 
CARDIOVASCULAR: 
JVP 
Inspection                                            Palpation 
Percussion                                           Auscultation 
Respiratory 
Abdominal 
Neurological 
 
RHEUMATOLOGICAL 
Axial joints involved 
Extra axial joints involved 
Joint deformities 
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INVESTIGATIONS: 
Haemoglobin:                      WBC count: 
Platelet count:                       ESR:                          CRP:  
         
X – Ray B/L Sacro iliac joints 
X-Ray of involved axial and peripheral joints 
 
Chest X-Ray 
12 LEAD ELECTROCARDIOGRAM 
ECHOCARDIOGRAM: 
Cardiac Position:                                 Pericardium: 
Great vessels:                                       IAS and IVS: 
Cardiac chambers: 
Right atrium:                                       Left atrium: 
Right Ventricle:                                  Left ventricle: 
 
Valves (velocities across the valves and grading of regurgitations as 
described earlier in methodology) 
Mitral                                                  Aortic             
Pulmonary                                          Tricuspid 
Aortic Root Diameter: 
Left Ventricular Internal diastolic Diameter: 
Left Ventricular Internal Systolic Diameter: 
EF%:               E/A: 
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CONSENT FORM 
Mr/Mrs/Ms…………………………………………………  
…………….(relationship)  of……………………………………(legal  
guardian) is being asked to be a participant in the research study titled   
“STUDY OF CARDIOVASCULAR MANIFESTATIONS IN 
ANKYLOSING SPONDYLITIS” in  CMC  Hospital, Coimbatore, 
conducted  by  Dr.BARATHI.L, Post Graduate Student in the 
Department of General Medicine, Coimbatore Medical College. He /she 
satisfies eligibility as per the inclusion criteria. You/legal guardian can ask 
any question you may have before agreeing to participate. 
Research Being Done 
STUDY OF CARDIOVASCULAR MANIFESTATIONS IN 
ANKYLOSING SPONDYLITIS 
Purpose of Research 
           Aim of the study is to find out the incidence of cardiovascular 
manifestations in ankylosing spondylitis 
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Procedures involved 
.       It includes details like age, sex, history of axial and peripheral joint 
involvement, cardiac symptoms and other extraarticular symptoms, 
treatment history and family history as well as clinical examination.  
       Investigations includes complete hemogram, ESR, CRP, X Ray 
bilateral sacroiliac joints and involved peripheral joints, Chest X-Ray, 
Electrocardiogram and Echocardiogram.  
Decline from Participation 
You have the option to decline from participation in the study existing 
protocol for your condition.  
Privacy and Confidentiality 
Privacy of individuals will be respected and any information about you or 
provided by you during the study will be kept strictly confidential.  
Authorization to publish Results 
Results of the study may be published for scientific purposes and/or 
presented to scientific groups, however you will not be identified.  
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STATEMENT OF CONSENT 
I volunteer and consent to participate in this study. I have read the consent 
or it has been read to me. The study has been fully explained to me, and  I 
may ask questions at any time.  
 
-------------------------------                           -------------------------------    
Signature /Left thumb impression                       Date  
(volunteer)    
 
--------------------------------                          --------------------------------  
Signature of witness                                               Date  
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xg;g[jy; gotk; 
 
bgah;   : 
taJ   : 
ghypdk;  : 
Kfthp  : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; bghJ kUj;Jt Jiwapy; gl;;l nkw;gog;g[ 
gapYk; khztp kU.y.ghujp mth;fs; nkw;bfhs;Sk; “Md;ifnyh!p'; 
!;ghd;iliyl;o!; nehapd; ,Uja btspg;ghLfs; gw;wpa Ma;t[” vd;gjpd; 
bra;Kiw kw;Wk; midj;J tpsf;f';fisa[k; nfl;Lf; bfhz;L vdJ 
re;njf';fis bjspt[g;gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; fye;J bfhs;s 
rk;kjpf;fpnwd;. 
,e;j ma;tpy; vd;idg; gw;wpa midj;J tptu';fs; ghJfhf;fg;gLtJld; 
,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij 
bjhptpj;Jf; bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j Ma;tpy; ,Ue;J ehd; 
tpyfpf; bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
,lk; : 
njjp :      ifbahg;gk; / nuif 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
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KEY TO MASTER CHART 
Sl.No :  Serial number 
OP/IP NO : Outpatient/Inpatient number 
Sex :  M – Male, F – Female 
Dis.dura :  Duration of AS in years 
Clin.Para :  Number of positive clinical 
parameters in AS (ASAS Criteria) 
CRP : C Reactive Protein in mg/dl 
Grading : Grading of sacroiliitis in AS by X 
Ray 
B/L : Bilateral 
U/L : Unilateral 
N : Normal 
Symptom : Cardiac symptoms 
C.megaly : Cardiomegaly 
CXR : Chest X Ray 
ECG : Electrocardiogram 
Echo : Echocardiogram 
E/A : Peak Early (E) / Late (A) trans mitral 
filling velocities (N – 0.75 to 1.5) 
EF : Ejection Fraction 
xiii 
 
A.Root.D : Aortic root diameter (N- 2.5 to 4) 
Card.M : Cardiac manifestations 
1 D AV Bl : First degree atrioventricular block 
2 D AV Bl : Second degree atrioventricular block 
LBBB : Left bundle branch block 
LAFB : Left anterior fascicular block 
LVH : Left ventricular hypertrophy 
LVDD : Left ventricular diastolic dysfunction 
A.R.Dil : Aortic root dilation   
Mild AR : Mild Aortic regurgitation 
Mod AR : Moderate Aortic regurgitation 
SevAR : Severe Aortic regurgitation 
Mod MR : Moderate Mitral regurgitation 
 
 xiv 
 
Sl.No Name OP/IP NO Age Sex Dis.Dura Clin.para CRP  Grading Symptom CXR ECG E/A EF% A.Root.D Echo Card.M 
1 S.Sahayaraj  16096 38 M 8 3 10 2 - B/L Nil N 1 D AV Bl. 0.95 64 3.6 N Yes 
2 N.Siva 114483 41 M 7 3 20 3 - U/L Nil N N 1.15 67 3.2 N No 
3 D.Palanisamy  583543 36 M 3 2 8 2 - B/L Nil N N 1.2 68 3.4 N No 
4 S.Bagyalakshmi 710297 39 F 4 3 11 4 - U/L Nil N N 1.5 65 2.8 N No 
5 L.Nanjappan 862017 40 M 6 4 26 3 - U/L Nil N N 1.34 64 2.8 N No 
6 G.Krishnaswamy  95222 42 M 8 3 10 3 - U/L Nil N N 1.45 69 4.2 A.R.Dil. Yes 
7 N.Maheshwari  622607 41 F 5 3 20 4 - U/L Nil N N 1.25 70 3.1 N No 
8 G.Nandhakumar  843556 35 M 3 2 16 3 - U/L Nil N N 1.35 67 3.4 N No 
9 V.Manikandan  1527 33 M 2 2 12 2 - B/L Nil N N 1.43 65 3.6 N No 
10 B.Suresh 68356 34 M 2 2 9 3 - U/L Nil N N 1.24 64 3.5 N No 
11 L.Jeyaraj 211099 37 M 5 3 18 2 -  B/L Nil N N 1.45 67 3.1 N No 
12 S.Sharmila  178978 34 F 4 2 8 3 - U/L Nil  N N 1 64 2.6 N No 
13 N.Ramasamy  58479 44 M 10 4 28 3 -U/L Dyspnoea C.megaly LVH 0.8 54 3.9 Mod AR Yes 
14 A.Musthaffa  800616 42 M 7 3 14 4 - U/L Nil N N 1 63 2.9 Mod MR Yes 
15 T.Dhanapal  128177 33 M 2 2 16 3 - U/L Nil N N 1.14 67 3.5 N No 
16 V.Shankar  233702 42 M 6 4 23 3 - B/L Nil N N 1.24 67 3.7 N No 
17 G.Veeramani  191443 36 F 5 3 26 2 - B/L Nil N N 1.12 68 3.6 N No 
18 R.Selvaraj 853671 38 M 6 2 9 3 - B/L Nil N N 1.1 69 2.9 N No 
19 S.Chinnapparaj  74207 37 M 5 2 10 4 -U/L Nil N N 1.25 70 3.1 N No 
20 N.Gurumoorthy  51873 36 M 3 3 19 3 - B/L Nil N N 1.34 68 3.2 N No 
21 J.Kalaivani  61284 34 F 4 3 30 3 - U/L Nil N N 1.18 65 3.4 N No 
22 M.Marimuthu  139266 40 M 6 4 24 2 -B/L Nil N N 1.46 67 3.2 N No 
23 J.Stephenraj  65285 43 M 10 3 14 3 = U/L C.Pain C.megaly LVH 0.7 51 4.6 Mod AR Yes 
24 D.Sivaprakasam  21829 36 M 5 3 25 3 - U/L Nil N N 1.36 67 2.8 N No 
25 M.Yogeshwaran  57864 37 M 6 2 5 4 - U/L Nil N N 1.21 68 2.7 N No 
26 M.Samsath  577695 40 F 9 3 10 3 - B/L Nil N 2 D AV Bl 0.85 69 2.6 N Yes 
27 L.Deivamani  7856 34 M 2 4 8 3 - U/L Nil N N 1.38 72 3.5 N No 
MASTER CHART CASES 
 xv 
 
Sl.No. Name OP/IP No. Age Sex Dis.Dura Clin.para CRP Grading Symptom CXR ECG E/A EP% A.Root.D Echo Card.M 
28 N.Duraisamy  198263 38 M 6 3 19 4 - U/L Nil N N 1,16 65 3.6 N No 
29 S.Nagarathnam  6479 36 M 4 3 11 2 -B/L Nil N N 1,42 68 2.8 N No 
30 B.Ragamathulla  2898 35 M 2 3 18 3 - U/L Nil N N 1.41 66 2.8 N No 
31 K.Srinivasan  61243 40 M 7 3 9 4 - B/L Nil N N 1.15 65 3.4 N No 
32 V.Ramesh  30625 41 M 8 3 9 4 - U/L Nil N LBBB 1.4 67 3.6 N Yes 
33 K.Jothi 44482 39 F 4 2 13 3 - U/L Nil N N 1.39 69 3.7 N No 
34 M.Damodarasamy  4317 41 M 5 3 20 2 - B/L Nil N N 1.16 68 3.8 N No 
35 S.Jeyaraman  58944 37 M 2 3 18 3 - U/L Nil N N 1.43 65 3.6 N No 
36 M.Kalimuthu  54872 38 M 4 4 30 3 - U/L Nil N N 1.5 64 2.8 N No 
37 M.Shanthi 432149 34 F 1 3 20 2 - B/L Nil N N 1.27 65 2.9 N No 
38 N.Arumugam  284729 35 M 3 2 9 3 - U/L Nil N N 0.9 69 3.6 N No 
39 B.Gowri 46565 41 F 6 3 17 3 - U/L Nil N N 1.14 67 3.5 Mild AR Yes 
40 M.Krishnaraj  167922 44 M 8 4 16 2 - B/L Nil N N 1.29 69 3.2 N No 
41  S.Sivakumar  25951 43 M 8 2 8 4 - B/L Nil N 1 D AV Bl. 1.18 70 3.4 N Yes 
42 N.Gopalakrishnan  51369 40 M 6 3 24 3 - B/L Nil N N 1.38 69 3.9 N No 
43 R.Natarajan  61248 38 M 5 2 10 2 -B/L Nil N N 1.26 65 3.4 N No 
44 S.Jothimani  43078 38 F 4 4 27 4 - U/L Nil N N 1.43 71 2.8 N No 
45 M.Abbas 2542 40 M 7 3 17 3 - B/L Nil N LAFB 1.17 68 2.9 N Yes 
46 M.Senthil kumar  53387 36 M 3 3 20 3 - U/L Nil N N 1.28 65 2.7 N No 
47 R.Manikandan  61794 39 M 6 4 19 4 - U/L Nil N N 1.5 67 2.8 N No 
48 L.Murugan  6572 34 M 4 3 17 3 - U/L Nil N N 1.42 68 3.6 N No 
49 V.Usha 193259 34 F 4 2 9 3 - U/L Nil N N 1.03 69 3.4 N No 
50 D.Jayaraman  63274 42 M 11 3 10 3 - B/L Dyspnoea C.megaly LVH 0.6 46 4.8 Sev AR Yes 
MASTER CHART CASES 
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Sl.No. Name OP. NO Age Sex  CRP  Symptom CXR ECG E/A EF% A.Root.D Echo Card.M 
1 V.Sathish kumar  12568 32 M 6 Nil N N 1.25 70 2.8 N No 
2 G.Mallika 45896 33 F 7 Nil N N 1.2 67 3.1 N No 
3 K.Prabakaran  21825 35 M 4 Nil N N 1.4 68 3.1 N No 
4 B.Deivanai  23671 41 F 3 Nil N N 1.03 68 3.4 N No 
5 D.Logeshwaran  8754 44 M 7 Nil N N 1.16 65 3.2 N No 
6 N.Mani 67690 38 M 6 Nil N N 1.45 67 3.3 N No 
7 R.Mariammal  56675 34 F 2 Nil N N 0.95 68 2.8 N No 
8 S.Pichaimuthu  45872 40 M 3 Nil N N 1.03 70 2.8 N No 
9 M.Gnanavel  453179 44 M 5 Nil N N 1.01 65 3.4 N No 
10 B.Vasudevan  156687 45 M 11 Nil N N 1.37 68 3.5 N No 
11  L.Yeshodha  23485 34 F 5 Nil N N 1.45 67 2.7 N No 
12 C.Baskaran  46572 33 M 6 Nil N N 1.3 64 2.7 N No 
13 N.Arogyaraj  56778 42 M 4 Nil N N 1.15 67 2.6 N No 
14 V.Jeyabalan  22435 36 M 4 Nil N N 1.4 69 2.8 N No 
15 S.Muthulakshmi  54712 38 F 3 Nil N N 1.35 66 2.9 N No 
16 A.Nagaraj 6469 38 M 5 Nil N N 0.88 68 3.1 N No 
17 V.Eswari 53245 39 F 6 Nil N N 1.4 67 3.2 N No 
18 A.Shahul hameed  56698 34 M 2 Nil N N 1.05 68 3.1 N No 
19 S.Gopalraj 36557 44 M 4 Nil N N 1.15 64 2.8 N No 
20 K.Balamurugan  98769 45 M 5 Nil N LAFB 1.2 65 2.6 N Yes 
21 M.Krishnaraj  87690 37 M 6 Nil N N 1.33 70 2.7 N No 
22 L.Sathyamoorthy  67453 41 M 14 Nil N N 1 68 3.1 N No 
23 N.Ponnammal  435617 42 F 5 Nil N N 1.2 67 3.4 N No 
24 J.Muthusamy  66687 36 M 6 Nil N N 1.41 68 3.5 N No 
25 N.Peter 78634 35 M 5 Nil N N 1.34 69 3.2 N No 
26 S.Karuppuraj  871235 44 M 5 Nil N N 1.35 64 2.6 N No 
27 A.Kadheeja  25487 41 F 8 Nil N N 1.21 70 2.7 N No 
28 R.Eshwaran  5980 34 M 9 Nil N N 1.25 68 2.8 N No 
29 P.Senthil 67553 32 M 4 Nil N N 1.41 65 2.6 N No 
MASTER CHART CONTROLS 
 xvii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl.No. Name OP. NO Age Sex  CRP  Symptom CXR ECG E/A EF% A.Root.D Echo Card.M 
30 K.Manjula  45987 39 F 3 Nil N N 1.2 65 3.1 N No 
31 D.Sethupathi  167436 41 M 3 Nil N N 1.31 67 3.2 N No 
32 N.Manickaraj  76534 44 M 2 Nil N N 1.15 68 3.2 N No 
33 D.Vasantha  98675 38 F 2 Nil N N 1.5 67 2.6 N No 
34 G.Yogaraj 125627 39 M 4 Nil N N 1.23 69 2.7 N No 
35  N.Chinnaraj  56987 40 M 10 Nil N N 1.44 67 2.7 N No 
36 S.Latha 212560 35 F 5 Nil N N 0.95 70 2.6 N No 
37 M.Pandian  64576 40 M 4 Nil N N 1.12 68 3.1 N No 
38 N.Rani 56547 38 F 5 Nil N N 1.15 66 3.1 N No 
39 G.Ponnusamy  65930 43 M 5 Nil N N 0.85 71 2.8 N No 
40 A.Mohammed kadar  56873 41 M 7 Nil N N 1.4 69 2.8 N No 
41 S.Kavitha 64578 33 F 8 Nil N N 1.3 68 2.7 N No 
42 B.Muthupandi  352479 34 M 5 Nil N N 1.26 67 3.1 N No 
43 G.Manickavel  45879 41 M 6 Nil N N 1.43 68 3.4 N No 
44 C.Baskaran  65794 38 M 6 Nil N N 1.35 65 2.8 N No 
45 N.Manju 44758 36 F 7 Nil N N 0.92 67 2.6 N No 
46 K.Kalaiarasan  45698 40 M 8 Nil N N 1.28 67 2.8 N No 
47 N.Selvaraj  4593 39 M 8 Nil N N 1.3 69 2.7 1 LVDD Yes 
48 D.Suresh 24956 32 M 5 Nil N N 0.9 65 2.6 N No 
49 R.Kalarani  76925 40 F 7 Nil N N 1.12 68 3.1 N No 
50 N.Kathikeyan  67942 34 M 8 Nil N N 1.2 69 2.8 N No 
MASTER CHART CONTROLS MASTER CHART CONTROLS 
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MASTER CHART - CASES WITH CARDIAC MANIFESTATIONS 
Sl.No Name 
OP/IP 
NO 
Age Sex Dis.Dura Clin.para CRP  Grading Symptom CXR ECG E/A EF% A.Root.D Echo 
1 S.Sahayaraj  16096 38 M 8 3 10 2 - B/L Nil N 1 D AV Bl. 0.95 64 3.6 N 
2 G.Krishnaswamy  95222 42 M 8 3 10 3 - U/L Nil N N 1.45 69 4.2 A.R.Dil. 
3 N.Ramasamy  58479 44 M 10 4 28 3 -U/L Dyspnoea C.megaly LVH 0.8 54 3.9 Mod AR 
4 A.Musthaffa  800616 42 M 7 3 14 4 - U/L Nil N N 1 63 2.9 Mod MR 
5 J.Stephenraj  65285 43 M 10 3 14 3 = U/L C.Pain C.megaly LVH 0.7 51 4.6 
Mod AR 
A.R.Dil. 
6 M.Samsath  577695 40 F 9 3 10 3 - B/L Nil N 2 D AV Bl 0.85 69 2.6 N 
7 V.Ramesh  30625 41 M 8 3 9 4 - U/L Nil N LBBB 1.4 67 3.6 N 
8 B.Gowri 46565 41 F 6 3 17 3 - U/L Nil N N 1.14 67 3.5 Mild AR 
9  S.Sivakumar  25951 43 M 8 2 8 4 - B/L Nil N 1 D AV Bl. 1.18 70 3.4 N 
10 M.Abbas 2542 40 M 7 3 17 3 - B/L Nil N LAFB 1.17 68 2.9 N 
11 D.Jayaraman  63274 42 M 11 3 10 3 - B/L Dyspnoea C.megaly LVH 0.6 46 4.8 
Sev AR 
A.R.Dil. 
 
